Tumorigenicity and radiosensitivity of related cell lines expressing distinct p53 mutants were analyzed in parallel with key components of the antioxidant metabolic pathway. Six sublines deriving from the same parental cell population and expressing either the mutant p53K130R or p53V270F were investigated. Both mutations abrogate the transcriptional activity of p53 as well as its ability to induce apoptosis. The cells expressing p53K130R showed a higher tumorigenicity and a higher radiosensitivity than those expressing p53V270F. An increase in tumorigenicity was associated with a decrease in manganese-containing superoxide dismutase activity, and with further decreases in the glutathione content and glutathione peroxidase (GPX) activity. A positive correlation was found between GPX activity, glutathione content and cell survival following ionizing irradiation. The fact that sister cell lines exhibit different tumorigenicity and radiosensitivity while expressing a mutant p53 further supports the notion that knowledge of p53 status is not sufficient to predict tumor outcome, especially the response to irradiation. A better understanding of antioxidant defenses might be more informative.
Introduction
In the last decade, research has produced remarkable advances in our understanding of cancer biology and cancer genetics. In particular, extensive studies were done on the tumor suppressor p53 gene. At the present time, p53 mutations have been described in more than half of the cancer cases, with a frequency of~70% in lung tumors (1) . The tumor suppressive effect of the p53 protein seems to rely essentially on its ability to induce apoptotic pathways (2) , thereby preventing genetically altered cells from spreading. The p53 gene status has been described to interfere with cell radiosensitivity. Although, a number of authors have reported that wild-type (wt)-p53 expression at the tumor level correlates with a higher radiosensitivity (3) (4) (5) , there are several examples in the literature showing the opposite (6) (7) (8) (9) . Therefore, p53 gene status may not necessarily predict cell sensitivity to irradiation, suggesting that other parameters are implicated.
Reactive oxygen species (ROS) are mutagenic compounds known to favor cell transformation (10) and to mediate the effect of ionizing radiations (11). Their levels are normally controlled by the antioxidant defense system including a number of small molecules such as glutathione and antioxidant enzymes: MnSOD (manganese-containing superoxide dismutase), CuZnSOD (copper-zinc-containing superoxide dismutase), CAT (catalase) and GPX (glutathione peroxidase). SOD catalyzes the dismutation of the superoxide radical into hydrogen peroxide, which is further degraded by the action of CAT and GPX. GPX also reduces organic hydroperoxides. Most cancer cells were found to have altered antioxidant enzymatic defenses, usually low MnSOD and CAT activity, in comparison to their normal counterpart (12) . Moreover, other data showed that down-regulation of antioxidant enzymes is determinant in the process of neoplastic transformation (13) . In agreement with this assumption, the addition of SOD or CAT prevents the radiation-induced or chemically induced transformation of rodent cells (13, 14) . Antioxidants were also demonstrated to have a protective effect against radiation damage (15) (16) (17) (18) (19) , although tumor cell radiosensitivity was not always related to the intrinsic level of cellular antioxidant activity (20) (21) (22) .
Analyzing a set of different epithelial cell lines derived from the same rat lung cell population treated with benzo[a] pyrene (B[a]P), we demonstrated previously that cell lines expressing the rat p53K130R mutant display a significantly lower survival after γ-irradiation (6) and higher tumorigenicity (23) than the sister cell lines expressing wt-p53. We extended our comparison with another set of cell lines derived from the same parental line, but expressing a distinct p53 mutant p53V270F. Results showed that the increase in radiosensitivity and tumorigenicity of cells expressing p53K130R could not be directly correlated with the inactivation of p53 tumor suppressor activity. In agreement with our previous results (6, 23) , we demonstrated a positive correlation between tumorigenicity and radiosensitivity. Finally, by analyzing key components of the antioxidant pathway, we showed that an increase in both malignancy and radiosensitivity was associated with a decrease in MnSOD and GPX activities and glutathione content. Table I lists the various cell lines used in the present study. They were obtained from the same parental epithelial cell line B[a]P established from a rat embryo lung explant treated with B[a]P. They were grown in Dulbecco's modified Eagle medium supplemented with 10% fetal calf serum, 2 mM glutamine and 100 U/ml of penicillin and 100 mg/ml streptomycin. Cells were incubated at 37°C in a humidified atmosphere with 5% CO 2 .
Materials and methods

Cell lines
Tumorigenicity
Animal procedures were carried out in accordance with French Government regulations. For each cell line, 2ϫ10 5 or 10 6 cells suspended in 0.2 ml of [5] Latency: time interval in days between inoculation and the appearance of a palpable tumor in (n) animals.
culture medium were injected subcutaneously in the right flank of nude mice. Groups of five or six 2-month-old animals were used for each test. Animals were checked regularly for tumor appearance.
Assays for antioxidant enzymes and glutathione content
For biochemical assays, cells were seeded at 1.7ϫ10 6 cells in 75 cm 2 culture flasks. Cells in exponential growth phase (2 days after seeding) and in the confluent state (7 days after seeding) were harvested by trypsination, washed twice in phosphate-buffered saline (PBS) and stored in liquid nitrogen until enzymatic extraction. Cell disruption was performed by successive freezing and thawing in 10 mM Tris-HCl pH 7.5, 0.1% Triton-X100 and 200 mM sucrose. The homogenate was centrifuged for 30 min at 20 000 g and the resulting supernatant was stored as aliquots at -80°C for further biochemical assays. The assays for SODs, CAT and GPX were determined using kinetic spectrophotometric measurements as described previously (24) . The amount of reduced and oxidized glutathione was determined according to Anderson (25) . All assays were done at least in duplicate on extracts from two different cell pellets. The values were normalized to the protein content measured with a Bio Rad kit (Bio Rad Laboratories, Hercules, CA) with bovine albumin as standard.
Western blot
For gel electrophoresis, 20 µg of proteins were loaded on 3.5% stacking and 12% separating polyacrylamide gels. After migration, the proteins were electrotransferred to nitrocellulose. The membranes were blocked and incubated for 1 h with specific antibodies for MnSOD, CuZnSOD and CAT (Valbiotech, Paris, France). Specific bands were revealed using a streptavidinalkaline phosphatase blotting detection kit (Amersham, UK), and their intensities were evaluated by using the NIH Image Software (Bethesda, MD).
Survival curves after irradiation
The clonogenic survival curves were established by seeding 1000 cells in 25 cm 2 culture flasks. The cells were irradiated 24 h later with a 60 Co-γ-source at doses of 2, 4, 6, 8, 10 and 12 Gy (dose rate 1 Gy min -1 ). Shamirradiated cells were used as controls. After 7-10 days in culture, cells were fixed with methanol, stained with 0.2% methylene blue and the surviving clones (colonies containing Ͼ50 cells) were counted.
Effect of glutathione and buthionine sulfoximine on B[a]P-related cell line survival after irradiation
For each cell line, 200 cells were seeded in 6-well culture plates. After 24 h in culture, cells were incubated for 12 h with 2 mM GSH (reduced glutathione) or 1 µM BSO (buthionine sulfoximine), a specific inhibitor of the glutathione synthesis pathway (26) . Cells were then washed three times with PBS before being irradiated at 6 Gy. Clonogenic survival was determined 7 days later as described previously. Statistical differences between treated and untreated groups were analyzed by ANOVA (software: Statview, Macintosh).
Results
The two sets of B[a]P-p53K130R-and B[a]P-p53V270F-related cell lines analyzed herein are presented in Table I . They derived from the same parental cell culture established from a rat embryo epithelial lung explant treated with B[a]P. The establishment of B[a]P-p53K130R, B[a]P-p53K130R-cl and B[a]P-p53K130R-ratTu cell lines was already described (23) . These three related cell lines are homozygous for a p53 missense mutation at codon 130 (AAG→AGG; K→R). We reported previously that cells expressing p53K130R are more sensitive to γ-irradiation and more oncogenic than the parental ones expressing wt-p53 (6, 23) . To establish whether or not these changes could be correlated with wt-p53 inactivation, we derived from the same parental culture the B[a]Pp53V270F cell line that expresses the p53V270F mutant (GTT→TTT point mutation at codon 270). Sequence analysis p53 mutation, antioxidant metabolism, tumorigenicity and radiosensitivity The assays were performed as described in the text from cells harvested in exponential (E) or in confluent phase (C [a]Pp53K130R-ratTu had comparable levels of glutathione and all antioxidant activities except for CAT. In comparison with B[a]P-p53V270F, the B[a]P-p53K130R-related sublines were mostly characterized by low MnSOD and GPX enzyme activities and low glutathione content. MnSOD level was comparable with that found in B[a]P-p53V270F-cl and B[a]P-p53V270F-mTu. GPX activity was reduced both in the exponential (2.5-6.4-fold) and confluent (4.8-8.6-fold) phases. The glutathione content was reduced by a factor of 1.8-2.5 in the exponential growth phase, whereas the difference appeared attenuated at confluence. As compared with B[a]P-p53V270F, a moderate decrease in CuZnSOD activity (1.4-1.8-fold) was observed in B[a]P-p53K130R-related cells in the exponential phase that was still attenuated at confluence. In the exponential phase, CAT activity in B[a]P-p53K130R-ratTu cells was comparable with that of the three B[a]P-p53V270F-related cell lines, but significantly higher in B[a]P-p53K130R and B[a]P-p53K130R-cl cells (2.3-and 5.3-fold, respectively). At confluence, CAT activity was notably higher in the three cell lines expressing p53K130R as compared with those expressing p53V270F. Western blot results presented in Figure 2 show that the variations in the levels of MnSOD, CuZnSOD and CAT parallel those of the corresponding enzymatic activities, indicating that the differences from one cell line to another depend on transcription or translation rates rather that on post-translational modifications. Figure 3 shows the radiation survival curves for the two cell lines B[a]P-p53V270F and B[a]P-p53V270F-cl that express the mutant p53V270F, and the two cell lines B[a]P-p53K130R and B[a]P-p53K130R-ratTu that express the mutant p53K130R. At the clinically relevant dose of 2 Gy, there was no significant difference in radiosensitivity between the two sets of cell lines. A significant difference was only seen for doses higher than 6 Gy. At these high doses, cells expressing p53V270F were significantly more radioresistant than those Two hundred cells were seeded in 6-well plates for 24 h. They were then incubated with 1 µM BSO or 2 mM GSH for 12 h. After three washes with PBS, the plates were irradiated at 6 Gy and analyzed for colony formation after 7 days. The values are means Ϯ SD (nϭ6), a P Ͻ 0.05, b P Ͻ 0.001 when compared with the corresponding control.
Clonogenic survival after ionizing radiation, effect of GSH
expressing p53K130R. Radiosensitivity of B[a]P-p53K130R-ratTu, B[a]P-p53K130R, B[a]P-p53V270F and B[a]Pp53V270F-cl cells was correlated with their antioxidant metabolism defense, as illustrated in Figure 4 , which shows a positive relationship between clonogenic survival following 6 Gy irradiation and GPX activity and GSH content of nonirradiated cells. To confirm further the implication of glutathione in the radiation response of these B[a]P cell lines, we investigated the effect of modulating the intracellular level of glutathione before radiation exposure by addition of exogenous glutathione or BSO at non-toxic concentrations. As indicated in Table IV, addition 
Discussion
A number of contradictory papers report the effect of wt-p53 inactivation on cellular response to γ-irradiation (4,7,9,29). According to Brown and Wouters (30) , a number of factors could account for the contradictory published results. Among them, the fact that cell killing has often been assessed in shortterm assays that are more influenced by the rate than the overall level of cell killing. This has tended to underestimate cell killing for cells not susceptible to apoptosis or having mutant p53. In this point of view, there are very few published findings comparing cell lines expressing different p53 mutants, most of the published data compare the radiosensitivity of wt-versus mutant-p53-expressing cells. The present paper was designed to compare the tumorigenicity and radiosensitivity of two sets of transformed cell lines, each expressing a distinct p53 mutant although both derived from the same parental one. We also aimed to determine if the tumorigenicity and radiosensitivity of these p53 mutants cell lines could be related to differences in their antioxidant defenses. To achieve this aim, starting from the same rat epithelium cell population treated with B[a]P, we established the two sets of B[a]Pp53K130R-and B[a]P-p53V270F-related cell lines that are homozygous for the p53 missense mutation p53K130R and p53V270F, respectively (see Table I ). Although both rat p53K130R and p53V270F missense mutations fully inactivate wt-p53 transcriptional activity and p53-dependent apoptosis, the B[a]P-p53K130R-and B[a]P-p53V270F-related cell lines present different tumorigenicity and radiosensitivity. The cell lines expressing the p53K130R mutant are clearly more radiosensitive at highdose irradiation and more tumorigenic than those expressing p53V270F. These results are consistent with the work of others (31) who have reported that conversion to a more malignant phenotype is not necessarily accompanied by an increase in 709 radioresistance. This is further supported by the results of Bristow et al. (32) showing an absence of correlation between intrinsic radioresistance and the acquisition of a metastatic phenotype, admittedly viewed as the most aggressive feature of tumor cells. A possible explanation is a gain of function brought about by the K130R mutation. Indeed, many in vitro and in vivo studies have suggested that some p53 mutants have acquired novel oncogenic functions that operate independently of the wild-type protein (reviewed in refs 33,34) .
Alternatively, differences in radiosensitivity and tumorigenicity between the B[a]P-p53K130R and B[a]P-p53V270F cell lines could be accounted for by unrelated cellular alterations co-selected with either the p53K130R or p53V270F mutant. As an example, alteration of the antioxidant defense system could interact both with the process of cell transformation (10) and with the response to ionizing radiation whose effect is largely mediated by ROS (11). Altered expression of antioxidant enzymes, associated with increased production of ROS, is found in a great variety of cancer cells. One of the most frequent alterations is the decrease in MnSOD activity, whereas modifications of the other antioxidant enzymes appear variable (12, 35) . Overexpression of MnSOD in various types of tumor cells leads to a decrease in their tumorigenicity (36) (37) (38) (39) (40) (41) , supporting the concept that MnSOD is a tumor suppressor gene (42) . The results of the present study show that a decrease in MnSOD activity, as well as GPX and glutathione alterations, is associated with an increase in tumorigenicity of B[a]P-related cell lines. The only difference found between the low and moderately tumorigenic B[a]P-p53V270F clones is a decreased MnSOD activity suggesting that this alteration is an early step during malignant conversion. Further progression is associated with a more general impairment of the antioxidant metabolism, i.e. additional decreases in GPX activity and glutathione content found in the highly tumorigenic B[a]P-p53K130R-related cell lines. These findings emphasize the importance of the balance between MnSOD, GPX and glutathione in tumor cell aggressiveness. Indeed, it was shown that GPX overexpression counteracts the tumor suppressive effect of MnSOD in human glioma cells (43) . Decreased GPX activity and glutathione content were found in a mouse model of hepatocarcinogenesis with very low GPX activity in the tumors ultimately formed in the animals. These metabolic alterations were paralleled by extensive DNA damage and increased ROS production (44) . Finally, tumor progression and DNA damage were shown to correlate with the decrease in MnSOD and GPX activities in murine fibrosarcoma cells (45) .
The B[a]P cell model appears particularly suitable when searching for cellular players involved in the radiation response in the absence of a functional p53 tumor suppressor activity. The present results show that B[a]P cell response to irradiation is closely related to their basal level of GPX activity and GSH levels, but not of the other antioxidant activities measured. This confirms the key role of the glutathione redox cycle in protecting lung cells against oxidative stress (46) and suggests that removal of peroxides is crucial for the survival of lung cells after radiation exposure, as proposed previously (47) . GPX plays an important role in the defense mechanisms by catalyzing the reduction of hydrogen peroxide and a large variety of hydroperoxides (48) . Its protective effect against ionizing radiation has been demonstrated using transfection assay in CHO cells (16) . GSH is the key regulator of intracellular redox status. It plays an essential role in the destruction of hydrogen and organic peroxides by providing a substrate for GPX (49) and acts also as a direct scavenger of ROS (50) . Moreover, GSH serves as a major reductant that maintains important regulatory proteins in the reduced state (51) . It was demonstrated to be involved in the protective effect of bcl-2 (52) and HSP25 (53) against irradiation. Our results demonstrate that increasing the cellular glutathione content significantly improves the clonogenic survival of all cell lines, except B[a]P-p53V270F. Treatment with BSO decreases the survival of B[a]P-ratTu, which have the lowest endogenous level of glutathione among B[a]P cell lines, suggesting a threshold level below which radiation survival is affected. Although the lack of B[a]P-p53V270F cell response to glutathione treatment remains to be elucidated, our results confirm that the endogenous level of glutathione is an important factor in the radiation survival of p53 mutant B[a]P sublines.
In conclusion, the present results show a higher tumorigenicity of cells expressing p53K130R as compared with those expressing p53V270F. Increase in malignancy is associated with a greater radiosensitivity. This is not related to a possible discriminatory effect of these two mutations on the p53 tumor suppressor activity since both fully inactivate the p53-dependent apoptosis and transcriptional activity. The results could be explained either by a gain of function brought about by the K130R mutation, or by other specific genetic alterations occurring during clonal selection. In fact, in our model differences in tumorigenicity and radiosensitivity of distinct p53 mutants are closely related to alteration of antioxidant defenses.
